Steven N. Chatfield

2013

In 2013, Steven N. Chatfield earned a total compensation of $916.1K as Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division at Emergent BioSolutions, a 9% increase compared to previous year.

Compensation breakdown

Bonus$185,647
Option Awards$147,738
Salary$361,887
Stock Awards$175,145
Other$45,675
Total$916,092

Chatfield received $361.9K in salary, accounting for 40% of the total pay in 2013.

Chatfield also received $185.6K in bonus, $147.7K in option awards, $175.1K in stock awards and $45.7K in other compensation.

Rankings

In 2013, Steven N. Chatfield's compensation ranked 7,026th out of 12,286 executives tracked by ExecPay. In other words, Chatfield earned more than 42.8% of executives.

ClassificationRankingPercentile
All
7,026
out of 12,286
43rd
Division
Manufacturing
2,500
out of 4,612
46th
Major group
Chemicals And Allied Products
763
out of 1,462
48th
Industry group
Drugs
565
out of 1,156
51st
Industry
Pharmaceutical Preparations
452
out of 890
49th
Source: SEC filing on April 7, 2014.

Chatfield's colleagues

We found five more compensation records of executives who worked with Steven N. Chatfield at Emergent BioSolutions in 2013.

2013

Daniel Abdun-Nabi

Emergent BioSolutions

Chief Executive Officer

2013

Fuad El-Hibri

Emergent BioSolutions

Chairman

2013

Barry Labinger

Emergent BioSolutions

Executive Vice President, Biosciences Division

2013

Adam Havey

Emergent BioSolutions

Executive Vice President, Biodefense Division

2013

Robert Kramer

Emergent BioSolutions

Chief Financial Officer

You may also like